Copyright
©The Author(s) 2022.
World J Gastroenterol. Feb 7, 2022; 28(5): 502-516
Published online Feb 7, 2022. doi: 10.3748/wjg.v28.i5.502
Published online Feb 7, 2022. doi: 10.3748/wjg.v28.i5.502
High risk | Intermediate risk | Low risk | |
Risk factors | (1) PSC; (2) Extensive involvement; (3) Moderate-severe active inflammation sustained over time (endoscopic or histological); (4) First-degree relative with CRC before age 50; (5) Stenosis or dysplasia detected during the previous five years; (6) Appearance of IBD at a young age; (7) If ileo-anal pouch: (a) Dysplasia; (b) Previous CRC; (c) PSC; and (d) Type C mucosa in the pouch | (1) Extensive colitis with mild or moderate sustained inflammatory activity (endoscopic or histological); (2) Inflammatory polyps; and (3) First-degree relative with CRC after age 50 | (1) Factors other than high and intermediate risk; and (2) If ileo-anal pouch: Without risk factors |
Surveillance | Annual | Every three years | Every five years |
- Citation: Huguet JM, Ferrer-Barceló L, Suárez P, Sanchez E, Prieto JD, Garcia V, Sempere J. Colorectal cancer screening and surveillance in patients with inflammatory bowel disease in 2021. World J Gastroenterol 2022; 28(5): 502-516
- URL: https://www.wjgnet.com/1007-9327/full/v28/i5/502.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i5.502